The Clinical Significance of Gallium-68 PSMA-11 PET-Derived SUVmax in the Management of Metastatic Hormone-Sensitive Prostate Cancer.

Saved in:
Bibliographic Details
Title: The Clinical Significance of Gallium-68 PSMA-11 PET-Derived SUVmax in the Management of Metastatic Hormone-Sensitive Prostate Cancer.
Authors: Kıkılı Cİ; Department of Medical Oncology, Koç University School of Medicine, Istabul, Türkiye., Kapar C; Department of Medical Oncology, Bakırköy Sadi Konuk Training and Research Hospital, Istabul, Türkiye., Yağmur FH; Department of Internal Medicine, Koç University School of Medicine, Istabul, Türkiye., Arslan E; Department of Nuclear Medicine and Molecular Imaging, Istanbul Education and Research Hospital, Istabul, Türkiye., Köylü B; Department of Medical Oncology, Koç University School of Medicine, Istabul, Türkiye., Kemik F; Department of Medical Oncology, Koç University School of Medicine, Istabul, Türkiye., Esen BH; Koç University School of Medicine, Istabul, Türkiye., Demir N; Department of Medical Oncology, Koç University School of Medicine, Istabul, Türkiye., Gültürk İ; Department of Medical Oncology, Istanbul Education and Research Hospital, Istabul, Türkiye., Polat M; Department of Nuclear Medicine and Molecular Imaging, Bakırköy Sadi Konuk Training and Research Hospital, Istabul, Türkiye., Selçukbiricik F; Department of Medical Oncology, Koç University School of Medicine, Istabul, Türkiye., Tural D; Department of Medical Oncology, Koç University School of Medicine, Istabul, Türkiye.
Source: The Prostate [Prostate] 2026 Jun; Vol. 86 (9), pp. 1043-1052. Date of Electronic Publication: 2026 Apr 22.
Publication Type: Journal Article
Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8101368 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0045 (Electronic) Linking ISSN: 02704137 NLM ISO Abbreviation: Prostate Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1097-0045
DOI:10.1002/pros.70185